Michael B. Kastan, MD, PhD
Michael B. Kastan, M.D., Ph.D., is the executive director of the Duke Cancer Institute. He earned medical and doctoral...
Archives: Governance
Michael B. Kastan, M.D., Ph.D., is the executive director of the Duke Cancer Institute. He earned medical and doctoral...
Dr. William G. Kaelin, Jr., is a professor at the Dana-Farber Cancer Institute in Boston, MA. He received his...
Lee J. Helman received his M.D. from the University of Maryland School of Medicine magna cum laude in 1980...
Dr. Bill Hait is global head, Janssen Research & Development, LLC, the global research and development arm of Janssen,...
Dr. Richard Gaynor started serving as president of research and development of Neon Therapeutics in 2016, after being the...
Dr. Elizabeth H. Blackburn is the Morris Herzstein professor of biology and physiology, in the Department of Biochemistry and...
Sanya A. Springfield is the Acting Deputy Director of the National Cancer Institute’s (NCI’s) Center to Reduce Cancer Health...
William G. Nelson, M.D., Ph.D., is the Marion I. Knott Director and professor of oncology and director of the...
Dr. Levine’s research focuses on the causes of cancer. In 1979, he and others discovered the p53 tumor suppressor...
A world leader of research in molecular biology and biochemistry, Dr. Phillip A. Sharp is institute professor at the...